Caffeine intakes of children from a biracial population: the Bogalusa Heart Study

M L Arbeit1, T A Nicklas, G C Frank

  • 1National Research and Demonstration Center Arteriosclerosis, Louisiana State University Medical Center, New Orleans.

Insights

White children consume more caffeine than Black children from age 1 to 17. Peak caffeine consumption occurs at ages 2, 3, 13, and 17, with carbonated beverages, chocolate, and tea being primary sources.

Area of Science:

  • Pediatric Nutrition
  • Dietary Habits
  • Public Health

Background:

  • Caffeine intake in children is not well-documented.
  • Understanding early-life caffeine consumption is crucial for long-term health.
  • Dietary patterns are established in early childhood.

Purpose of the Study:

  • To investigate caffeine intake patterns in a biracial sample of infants and children.
  • To identify trends and sources of caffeine consumption from infancy through adolescence.

Main Methods:

  • Utilized 24-hour dietary recalls from 1,284 children aged 6 months to 17 years.
  • Collected data at multiple time points: 6 months, 1, 2, 3, 4, 13, 15, and 17 years.
  • Included additional cohorts to assess temporal trends in caffeine intake.

Main Results:

  • White children consumed significantly more caffeine than Black children from age 1 to 17.
  • Peak caffeine consumption periods were identified at ages 2, 3, 13, and 17 years.
  • Regular carbonated beverages, chocolate, and tea were the most frequent caffeine sources.

Conclusions:

  • Caffeine intake begins early in life and shows racial and age-related differences.
  • Snacks are a significant contributor to children's caffeine intake.
  • Consistent caffeine intake levels were observed in 10-year-olds over a decade.

Related Concept Videos

Experimental Designs01:16

Experimental Designs

An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...